Apolipoprotein E as a β-amyloid-independent factor in Alzheimer's disease

被引：0

作者：

Wolf A.B. ^{[1
]}

Valla J. ^{[2
,3
]}

Bu G. ^{[4
]}

Kim J. ^{[4
]}

Ladu M.J. ^{[5
]}

Reiman E.M. ^{[3
,6
,7
,8
]}

Caselli R.J. ^{[3
,9
]}

机构：

[1] Medical Scientist Training Program, University of Colorado Anschutz Medical Campus, Mail Stop B176, Aurora, CO 80045

[2] Department of Biochemistry, Midwestern University, Glendale, AZ 85308

[3] Arizona Alzheimer's Consortium, Phoenix, AZ

[4] Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224

[5] Department of Anatomy and Cell Biology, University of Illinois, Chicago, IL 60612

[6] Banner Alzheimer's Institute, Banner Good Samaritan PET Center, Phoenix, AZ 85006

[7] Neurogenomics Division, Translational Genomics Research Institute (TGen), Phoenix, AZ 85004

[8] Department of Psychiatry, University of AZ, Phoenix, AZ 85004

[9] Department of Neurology, Mayo Clinic Arizona, Scottsdale, AZ 85259

来源：

Alzheimer's Research & Therapy | / 5卷 / 5期

关键词：

Cerebral Amyloid Angiopathy; Cerebral Metabolic Rate; apoE Isoforms; Human apoE4; apoE4 Mouse;

D O I：

10.1186/alzrt204

中图分类号：

学科分类号：

摘要：

APOE, which encodes apolipoprotein E, is the most prevalent and best established genetic risk factor for late-onset Alzheimer's disease. Current understanding of Alzheimer's disease pathophysiology posits an important role for apolipoprotein E in the disease cascade via its interplay with β-amyloid. However, evidence is also emerging for roles of apolipoprotein E in the disease process that are independent of β-amyloid. Particular areas of interest are lipid metabolism, tau pathology, neuroenergetics, neurodevelopment, synaptic plasticity, the neurovasculature, and neuroinflammation. The intent of this article is to review the literature in each of these areas. © 2013 BioMed Central Ltd.

引用

共 50 条

[1] Apolipoprotein E as a β-amyloid-independent factor in Alzheimer's disease
Wolf, Andrew B.
Valla, Jon
Bu, Guojun
Kim, Jungsu
LaDu, Mary Jo
Reiman, Eric M.
Caselli, Richard J.
ALZHEIMERS RESEARCH & THERAPY, 2013, 5 (05)
[2] Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
Pimplikar, Sanjay W.
Nixon, Ralph A.
Robakis, Nikolaos K.
Shen, Jie
Tsai, Li-Huei
JOURNAL OF NEUROSCIENCE, 2010, 30 (45): : 14946 - 14954
[3] Amyloid-dependent and amyloid-independent effects of tau in Alzheimer's disease
Therriault, J.
Pascoal, T.
Rosa-Neto, P.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 117 - 118
[4] Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease
Hyman, Bradley T.
ARCHIVES OF NEUROLOGY, 2011, 68 (08) : 1062 - 1064
[5] Amyloid-independent pathogenesis for Alzheimer's disease: implications for drug design
Wolfe, Michael S.
MEDICINAL CHEMISTRY RESEARCH, 2024, 33 (08) : 1330 - 1338
[6] Plasma Alzheimer's disease biomarker variability: Amyloid-independent and amyloid-dependent factors
Lee, Eun Hye
Kang, Sung Hoon
Shin, Daeun
Kim, Young Ju
Zetterberg, Henrik
Blennow, Kaj
Gonzalez-Ortiz, Fernando
Ashton, Nicholas J.
Cheon, Bo Kyoung
Yoo, Heejin
Ham, Hongki
Yun, Jihwan
Kim, Jun Pyo
Kim, Hee Jin
Na, Duk L.
Jang, Hyemin
Seo, Sang Won
ALZHEIMERS & DEMENTIA, 2025, 21 (01)
[7] Apolipoprotein E and Alzheimer's disease - A role in amyloid catabolism
Poirier, J
ALZHEIMERS DISEASE: A COMPENDIUM OF CURRENT THEORIES, 2000, 924 : 81 - 90
[8] Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease
Evan Dorey
Nina Chang
Qing Yan Liu
Ze Yang
Wandong Zhang
Neuroscience Bulletin, 2014, 30 (02) : 317 - 330
[9] Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease
Evan Dorey
Nina Chang
Qing Yan Liu
Ze Yang
Wandong Zhang
Neuroscience Bulletin, 2014, 30 : 317 - 330
[10] Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease
Dorey, Evan
Chang, Nina
Liu, Qing Yan
Yang, Ze
Zhang, Wandong
NEUROSCIENCE BULLETIN, 2014, 30 (02) : 317 - 330

← 1 2 3 4 5 →